ACOR News and Press, Acorda Therapeutics Inc. From 10/27/20

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its third quarter 2020 update and financial results on Tuesday, November 3 at 4:30 p.m. ET. To participate in the Webcast/Conference call, please note there is a new pre-registration...

Acorda Therapeutic (ACOR) jumps 69% in pre-market trading, as it announces receiving a $15M milestone payment from Biogen International GmbH.The payment is with respect to Acorda’s license agreement with Biogen, based on Biogen’s ex-U.S. net sales of Fampyra excee...

Looking For High Volume Penny Stocks To Buy? Here’s What Analysts Think Of These 5 Looking for penny stocks to buy can be a task. That’s especially true considering that there are so many choices when it comes to stocks under $5. That and the idea that investors ar...

Do You Agree With Analysts On These Penny Stocks? Whether you’re new to penny stocks or a seasoned vet, analysts ratings are something that can act as a catalyst for these cheap stocks. As much as I would like to say that’s a positive, analysts actions can trigger move...

4 Top Penny Stocks To Watch Before Next Week A penny stock is referred to as any equity that trades below $5. In 2020, this niche of the market has been growing in popularity for a few reasons. People are searching for more ways to make money in 2020. This has people wanting to ma...

HOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced that Michael W. Rogers joined the Company’s Board of Directors. Mr. Rogers is a biopharmaceutical vet...

Acorda Therapeutics, Inc. (ACOR) Q2 2020 Results Earnings Conference Call August 04, 2020, 04:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen - Founder, CEO, President Conference Call Participants Michael Yee - Jefferies Kenneth Shi...

INBRIJA ® (levodopa inhalation powder) 2Q 2020 net revenue of $4.7 million AMPYRA ® (dalfampridine) 2Q 2020 net revenue of $26.1 million INBRIJA dispensed cartons increase 13% over 1Q 2020 Acorda Therapeutics, Inc. (NASDAQ: ACOR ) today provided a business update...

Scheduled to Reconvene August 28, 2020 at 9:00 a.m. Eastern Time at Company Headquarters to Vote on Proposal One Acorda Therapeutics, Inc. (Nasdaq: ACOR ) convened its Special Meeting of Stockholders on July 31, 2020, and stockholders approved proposals to authorize the Company’...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2020 update and financial results on Tuesday, August 4 at 4:30 p.m. ET. To participate in the Webcast/Conference call, please note there is a new pre-registration proces...